Search Now

Recommendations

Monday, April 02, 2007

Market Watch & Insider Trades


Insider Trades:
Gujarat Ambuja Cement Ltd: Shri A L Kapur, Director has sold in open market 90000 equity shares of Gujarat Ambuja Cement Ltd on 26th March, 2007.

Bilpower Limited: Rajendra Kumar Choudhary, Director has purchased from open market 91000 equity shares of Bilpower Limited on 29th Mach, 2007.

Deepak Fertilizers And Petrochemicals Corporation Limited: Shri Chimanlal K Mehta, Chairman has sold in open market 1000000 equity shares of Deepak Fertilizers And Petrochemicals Corporation Limited on 22nd, 23rd and 26th March, 2007

Market Volumes:
The turnover on NSE was down by 33% to Rs75.17bn. BSE Pharma index was the major gainer and gained 1.89%. BSE Metal index (up 1.71%), BSE FMCG index (up 1.57%), BSE Auto index (up 1.36%) and BSE Consumer Durable index (up 0.98%) were among the other major gainers.

Volume Toppers:
IFCI, Sakthi Sugar, ITC, SAIL, Ashok Leyland, Balrampur Chini, Bajaj hindusthan, Gujarat NRE, Gujarat Ambuja, Renuka Sugar, NTPC, Tata Steel, R Com, hindalco, IDFC, Satyam Computer and Rana Sugar.

Upper Circuit:
Amara Raja, Flex Industries, Shah Alloys, Alps Industries, McLeod Russel, Nirlon, Swan Mills, DS Kulkarni, Ganesh Housing, Goldiam International, Taneja Aerospace, Tanla and Vakran Software.

Delivery Delight:
Aptech, Bajaj Auto, Bajaj Hindustan, Eveready Industries, HLL, Indiabulls Financial Services, Indian Hotels, Indian Hotels, L&T, Maharashtra Seamless, NTPC, NDTV, Patel Engineering, Ranbaxy Laboratories, Reliance Capital and Sun Pharmaceuticals.

Brokers Recommendation:
Aurobindo Pharma – Buy from Edelweiss

Long Term investment:
Dr Reddy’s Laboratories

Major News Headlines
Inflation unchanged at 6.46% in week ended March 17

Hero Honda says March sales flat at about 275,000 units

Gail plans to spend Rs180bn on expansion

Patel Eng-Gammon JV bags Rs8.06bn order from Rampur Hydro Electro Project

Tata Power buys 30% in 2 Indonesian coal mines

Moser Baer arm buys 40% in Slovenian Company

Abbott Labs sues Ranbaxy, Teva, Sandoz to block regulatory nod of a generic version of antibiotic Omnicef